US 12234460
Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
granted A61KA61K31/4535A61K31/565
Quick answer
US patent 12234460 (Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/4535, A61K31/565, A61K31/57, A61K31/663